Twenty patients with Myelodysplastic Syndrome (MDS) were diagnosed in University Hospital, Kuala Lumpur over a 5 year period. They were subclassified using the French American British (FAB) criteria. 90% of the patients were above 40 years old and the sex ratio was about equal. The predominant presenting symptom was anaemia and there was paucity of physical signs at presentation. Patients with 'aggressive' subtypes of MDS i.e. refractory anaemia with excess blasts (RAEB), refractory anaemia with excess blasts in transformation (RAEB(-)+) and chronic myelomonocytic leukaemia (CMML) had more frequent thrombocytopenia and neutropenia and their marrow pictures frequently had dysmegakaryopoiesis and dysgranulopoiesis as compared to more the "ben...
In a retrospective analysis of 113 patients with primary myelodysplastic syndromes (MDS) diagnosed a...
Sixty-nine patients with myelodysplastic syndromes (MDS) were followed at Dokuz Eylul University Med...
Myelodysplastic syndrome (MDS) is a clonal haematopoietic stem cell disorder characterised by ineffe...
Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between J...
We report on our experience relating to 62 patients with myelodysplastic syndrome (MDS) aged less th...
1. Classification Peripheral blood cytopenias in combination with a hy-percellular bone marrow assoc...
A retrospective analysis was done on 113 patients (median age 73 years) with myelodysplastic syndrom...
The myelodysplastic syndrome (MDS) patients diagnosed between 1986 and 1992 were evaluated. There we...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
peer reviewedThe myelodysplastic syndromes (MDS) are a heterogeneous group of disorders characterize...
Myelodysplastic syndromes (MDS) are fairly common hematological disorder of elderly. They are a grou...
The authors conducted a systematic review of the medical literature published in the past 15 years o...
Myelodysplastic syndromes (MDS) are a type of blood cancer that derive from ineffective hematopoiesi...
Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by morphol...
One of the major changes suggested by the World Health Organization (WHO) classification with respec...
In a retrospective analysis of 113 patients with primary myelodysplastic syndromes (MDS) diagnosed a...
Sixty-nine patients with myelodysplastic syndromes (MDS) were followed at Dokuz Eylul University Med...
Myelodysplastic syndrome (MDS) is a clonal haematopoietic stem cell disorder characterised by ineffe...
Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between J...
We report on our experience relating to 62 patients with myelodysplastic syndrome (MDS) aged less th...
1. Classification Peripheral blood cytopenias in combination with a hy-percellular bone marrow assoc...
A retrospective analysis was done on 113 patients (median age 73 years) with myelodysplastic syndrom...
The myelodysplastic syndrome (MDS) patients diagnosed between 1986 and 1992 were evaluated. There we...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
peer reviewedThe myelodysplastic syndromes (MDS) are a heterogeneous group of disorders characterize...
Myelodysplastic syndromes (MDS) are fairly common hematological disorder of elderly. They are a grou...
The authors conducted a systematic review of the medical literature published in the past 15 years o...
Myelodysplastic syndromes (MDS) are a type of blood cancer that derive from ineffective hematopoiesi...
Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by morphol...
One of the major changes suggested by the World Health Organization (WHO) classification with respec...
In a retrospective analysis of 113 patients with primary myelodysplastic syndromes (MDS) diagnosed a...
Sixty-nine patients with myelodysplastic syndromes (MDS) were followed at Dokuz Eylul University Med...
Myelodysplastic syndrome (MDS) is a clonal haematopoietic stem cell disorder characterised by ineffe...